Security Investigation

Elevance Health, Inc. (NYSE: ELV)

52 Days left to seek lead plaintiff status.

Company Name:Elevance Health, Inc. (NYSE: ELV)
Stock Symbol:NYSE: ELV
Court:Southern District of Indiana
Class Period Start:04/18/2024
Class Period End (inclusive):10/16/2024
Filing Deadline:07/11/2025

Contact a Lawyer Now

(877) 515-1850

Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 11, 2025 to file lead plaintiff applications in a securities class action lawsuit against Elevance Health, Inc. (“Elevance” or the “Company”) (NYSE: ELV).

Elevance and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.

On October 17, 2024, the Company released its financial results for 3Q 2024, disclosing that the Company had missed consensus earnings per share (“EPS”) expectations for the quarter by $1.33, or 13.7%, “due to elevated medical costs in [its] Medicaid business,” and that it was lowering EPS guidance for 2024 from $37.20 to $33.00, or 11.3%, as it expected  Medicaid issues to continue.

On this news, the price of Elevance’s shares plummeted by $52.61 per share, or 10.6%, from a closing price of 496.96 on October 16, 2024, to a closing price of $444.35 on October 17, 2024.

If you purchased shares of Elevance Health and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (lewis.kahn@ksfcounsel.com), or fill out the form on this page.

The case is Miller v. Elevance Health, Inc., No. 25-cv-923

Click here to read the first filed complaint.